Femasys Past Earnings Performance

Past criteria checks 0/6

Femasys's earnings have been declining at an average annual rate of -20.1%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 0.8% per year.

Key information

-20.1%

Earnings growth rate

74.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate0.8%
Return on equity-303.3%
Net Margin-1,436.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Femasys (NASDAQ:FEMY) Has Debt But No Earnings; Should You Worry?

Oct 31
Femasys (NASDAQ:FEMY) Has Debt But No Earnings; Should You Worry?

Shareholders May Be More Conservative With Femasys Inc.'s (NASDAQ:FEMY) CEO Compensation For Now

Jul 05
Shareholders May Be More Conservative With Femasys Inc.'s (NASDAQ:FEMY) CEO Compensation For Now

Health Check: How Prudently Does Femasys (NASDAQ:FEMY) Use Debt?

Apr 03
Health Check: How Prudently Does Femasys (NASDAQ:FEMY) Use Debt?

Here's Why We're Watching Femasys' (NASDAQ:FEMY) Cash Burn Situation

Sep 27
Here's Why We're Watching Femasys' (NASDAQ:FEMY) Cash Burn Situation

Femasys commercially launches Femcerv for cervical cancer screening

Sep 29

Femasys GAAP EPS of -$0.22 beats by $0.01, revenue of $0.3M misses by $0.01M

Aug 10

We Think Femasys (NASDAQ:FEMY) Needs To Drive Business Growth Carefully

May 22
We Think Femasys (NASDAQ:FEMY) Needs To Drive Business Growth Carefully

Femasys: Revolutionizing Female Reproduction

Jul 16

Revenue & Expenses Breakdown

How Femasys makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:FEMY Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241-18108
30 Jun 241-1798
31 Mar 241-1587
31 Dec 231-1487
30 Sep 231-1376
30 Jun 231-1266
31 Mar 231-1166
31 Dec 221-1166
30 Sep 221-1166
30 Jun 221-1055
31 Mar 221-955
31 Dec 211-844
30 Sep 211-744
30 Jun 211-634
31 Mar 211-734
31 Dec 201-734
31 Dec 191-1157

Quality Earnings: FEMY is currently unprofitable.

Growing Profit Margin: FEMY is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FEMY is unprofitable, and losses have increased over the past 5 years at a rate of 20.1% per year.

Accelerating Growth: Unable to compare FEMY's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FEMY is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).


Return on Equity

High ROE: FEMY has a negative Return on Equity (-303.25%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 12:52
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Femasys Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Keay NakaeChardan Capital Markets, LLC
Emily BodnarH.C. Wainwright & Co.
Catherine NovackJonesTrading Institutional Services, LLC